Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-96,051
Closed -$514K 4350
2025
Q3
$514K Hold
96,051
﹤0.01% 3936
2025
Q2
$517K Buy
96,051
+24,283
+34% +$96.3K ﹤0.01% 3911
2025
Q1
$200K Hold
71,768
﹤0.01% 4077
2024
Q4
$224K Hold
71,768
﹤0.01% 4083
2024
Q3
$221K Sell
71,768
-65,051
-48% -$214K ﹤0.01% 4121
2024
Q2
$465K Buy
136,819
+11,493
+9% +$37.6K ﹤0.01% 4030
2024
Q1
$380K Buy
125,326
+18
+0% +$63 ﹤0.01% 4074
2023
Q4
$528K Hold
125,308
﹤0.01% 4017
2023
Q3
$856K Buy
125,308
+4,038
+3% +$35.7K ﹤0.01% 3891
2023
Q2
$1.26M Buy
121,270
+31,196
+35% +$279K ﹤0.01% 3826
2023
Q1
$628K Buy
90,074
+15,991
+22% +$139K ﹤0.01% 4054
2022
Q4
$447K Buy
74,083
+1,300
+2% +$9.6K ﹤0.01% 4124
2022
Q3
$574K Buy
72,783
+22
+0% +$257 ﹤0.01% 4176
2022
Q2
$990K Sell
72,761
-24,566
-25% -$406K ﹤0.01% 4094
2022
Q1
$1.91M Sell
97,327
-6,563
-6% -$131K ﹤0.01% 3976
2021
Q4
$3.56M Buy
103,890
+10,675
+11% +$429K ﹤0.01% 3795
2021
Q3
$5.09M Buy
93,215
+10,847
+13% +$654K ﹤0.01% 3649
2021
Q2
$6.05M Buy
82,368
+44,944
+120% +$4.49M ﹤0.01% 3491
2021
Q1
$3.42M Buy
+37,424
New +$3.63M ﹤0.01% 3707

Other funds holding CVAC

Vanguard Group's CVAC Position: Q4 2025 in Review

Vanguard Group sold out of CureVac (CVAC) in Q4 2025, closing a stake of 96,051 shares — an estimated $514K sold.

Vanguard Group first reported a position in CVAC in Q1 2021 and held it in 19 quarters. The position peaked at $6.05M in Q2 2021. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

  • Vanguard Group reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
  • Vanguard Group sold 96,051 CureVac shares in Q4 2025, an estimated $514K.
  • Vanguard Group first reported a position in CureVac in Q1 2021 and held it in 19 quarters.
  • Vanguard Group's CureVac position peaked at $6.05M in Q2 2021.
  • 57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.